FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21245011000001106: Linagliptin 2.5mg / Metformin 1g tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70877001000001113 Linagliptin 2.5mg / Metformin 1g tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70877101000001114 Linagliptin 2.5mg / Metformin 1g tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

4 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Linagliptin 2.5mg / Metformin 1g tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Has active ingredient Linagliptin false Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Is a Linagliptin + Metformin true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Is a Linagliptin + Metformin false Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Has specific active ingredient Linagliptin false Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Has active ingredient Metformin false Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Has specific active ingredient Linagliptin true Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets Is a Product containing linagliptin and metformin false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Jentadueto 2.5mg/1000mg tablets (CST Pharma Ltd) Is a True Linagliptin 2.5mg / Metformin 1g tablets Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 60 tablet Has VMP True Linagliptin 2.5mg / Metformin 1g tablets Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Mawdsley-Brooks & Company Ltd) Is a True Linagliptin 2.5mg / Metformin 1g tablets Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (DE Pharmaceuticals) Is a True Linagliptin 2.5mg / Metformin 1g tablets Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Is a True Linagliptin 2.5mg / Metformin 1g tablets Inferred relationship Existential restriction modifier
Linagliptin 2.5mg / Metformin 1g tablets 56 tablet Has VMP True Linagliptin 2.5mg / Metformin 1g tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start